Condition: BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4


rs1057521922 in RAD51D;RAD51L3-RFFL gene and BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4 PMID 26261251 2015 Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.

PMID 25452441 2015 Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.

PMID 10749867 2000 Evidence for simultaneous protein interactions between human Rad51 paralogs.

PMID 21111057 2011 Structural and functional characterization of the N-terminal domain of human Rad51D.

PMID 19327148 2009 Functional characterization and identification of mouse Rad51d splice variants.

PMID 14704354 2004 Domain mapping of the Rad51 paralog protein complexes.

PMID 26720727 2016 Use of 5-Hydroxytryptophan Labeled With Carbon 11 in Social Anxiety Disorder.

PMID 26720728 2016 Inherited Mutations in Women With Ovarian Carcinoma.

PMID 21822267 2011 Germline mutations in RAD51D confer susceptibility to ovarian cancer.

PMID 28724667 2017 Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients.

PMID 26845104 2016 Improving performance of multigene panels for genomic analysis of cancer predisposition.

PMID 16717288 2006 Disparate requirements for the Walker A and B ATPase motifs of human RAD51D in homologous recombination.

PMID 22986143 2012 Loss of function germline mutations in RAD51D in women with ovarian carcinoma.

PMID 28646019 2017 Functionally Null RAD51D Missense Mutation Associates Strongly with Ovarian Carcinoma.

PMID 26976419 2016 Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.

PMID 24139550 2013 Germline mutation in the RAD51B gene confers predisposition to breast cancer.

PMID 25186627 2015 Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.

PMID 26057125 2015 Mutation Analysis of the RAD51C and RAD51D Genes in High-Risk Ovarian Cancer Patients and Families from the Czech Republic.

PMID 24130102 2014 About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants.

PMID 26681312 2016 Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.

PMID 27083178 2016 Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.

PMID 27433846 2016 Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.

PMID 27153395 2016 Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.

PMID 28008555 2017 Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.

PMID 23372765 2013 Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancer.

PMID 22652533 2012 A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer.

rs1060502959 in RAD51L3-RFFL;RAD51D gene and BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4 PMID 10749867 2000 Evidence for simultaneous protein interactions between human Rad51 paralogs.

PMID 14704354 2004 Domain mapping of the Rad51 paralog protein complexes.

PMID 19327148 2009 Functional characterization and identification of mouse Rad51d splice variants.

PMID 21111057 2011 Structural and functional characterization of the N-terminal domain of human Rad51D.

PMID 26720728 2016 Inherited Mutations in Women With Ovarian Carcinoma.

PMID 21822267 2011 Germline mutations in RAD51D confer susceptibility to ovarian cancer.

PMID 26261251 2015 Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.

PMID 23372765 2013 Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancer.

PMID 25445424 2015 Breast cancer in a RAD51D mutation carrier: case report and review of the literature.

PMID 22415235 2012 Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families.

PMID 26681312 2016 Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.

PMID 27978560 2017 Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.

PMID 24130102 2014 About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants.

PMID 28591191 2017 Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability.

PMID 28724667 2017 Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients.

PMID 25452441 2015 Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.

PMID 27913932 2017 Almost 2% of Spanish breast cancer families are associated to germline pathogenic mutations in the ATM gene.

PMID 26822949 2016 Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2-negatively tested breast cancer patients.